Locations:
Search
Patient reported outcomes differentiate between remission and low disease activity in PsA
Prevention of progression and complications is the primary goal
A unique approach provides long-lasting results with minimal impact on the disease state
A broad differential diagnosis
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Results of the largest population-based study to date
Scientific evidence for and clinical experience of using JAK inhibitors in the treatment of COVID-19
Case-control study assesses risk factors that play a role in tumor necrosis factor-α inhibitor-induced psoriasis
Clinical features that should make clinicians suspect vasculopathy
The progressive, nonspecific symptoms of subacute infective endocarditis can be subtle
Benefit/AFF risk ratio favors 3–5 years of treatment
Advertisement
Advertisement